ã¡ãã£ã¢èšäº
åéïŒ29æ¥é
ä¿¡èšäºïŒ-ãã³ããã¯ã¯ãã³æ¥çš®å§åãæ¹å®ãå¥åº·ãªåã©ãã¯å¿
ãããå¿
èŠãªã
ããºãææ°ããŒã¯ 5,159
twitterã³ã¡ã³ã 2,048ä»¶äž 401ïœ500件
èŠèœãšããŠã
æ¥æ¬èªçã®ã¿ã€ãã«ãšè±èªçã®ã¿ã€ãã«ãéããããããã¯æªæãããããããªãïŒ
ãå¥åº·ãªåã©ãå¿ èŠãªããã¯åæã«ç¡ã
è±èªçïŒWHO revises COVID-19 vaccine recommendations for Omicron-era
æ¥æ¬èªçã®ã¿ã€ãã«ãšè±èªçã®ã¿ã€ãã«ãéããããããã¯æªæãããããããªãïŒ
ãå¥åº·ãªåã©ãå¿ èŠãªããã¯åæã«ç¡ã
è±èªçïŒWHO revises COVID-19 vaccine recommendations for Omicron-era
ðãã£ã±ã¯ã¯ãã³ããããã
ã¯ã¯ãã³æšé²æŽŸã®æ¹ã
ããã®ãã¥ãŒã¹ã«å¯ŸããŠã®ã³ã¡ã³ããæ¯éãšããé¡ãããããŸãã
éããå£ãå¡ãããã
ããã倫婊ã¯3åæ¥çš®ãããã©åã©ãã¯è¿·ã£ãŠæããªãã£ãã®ãå¥åº·ãªãæããªããŠã倧äžå€«ã ãããªã®ã§äžå
ãå®å¿ð®âðš
æ¯åæåž³ã«ã¯ã¯ã¯ãã³ã®é
ç®ãšããŠèšèŒãããŠãããšèããŸããã乳幌å
ã«å¯ŸããŠã¯ã©ãããã®ã§ãããã
ãŸã岩æçã§2011幎12æ24æ¥ä»å¹Ž1æ15æ¥ïŒ3æ11æ¥ã«æ¥çš®ããŠããŸãããã©ããããã§ãããã
ãŸã岩æçã§2011幎12æ24æ¥ä»å¹Ž1æ15æ¥ïŒ3æ11æ¥ã«æ¥çš®ããŠããŸãããã©ããããã§ãããã
ãã£ãšæ©ãçºè¡šããŠãããã°ããã£ãã®ã«
èªåã®åšãã§ã¯ãŸã 話èããªããã©ãåäŸã«ãã®ã¯ã¯ãã³æããã人ã£ãŠãããªã«ããã®ããªããïŒæãã
åæãèªããšãã©ãèš³ããããå¥åº·ãªåäŸå¿
èŠãªããã«ãªããã ãããã€ã¿ãŒæ¥æ¬èªçã®ç·šééšã¯åã¯ã¯ã§ããããšãå€æã
WHOã¯æ°åã³ããã¯ã¯ãã³ã®åäŸãžã®æ¥çš®å§åãä¿®æ£ããŸãããååŽçã¯ã©ãããã®ã§ããããã
WHO ãªããŠãè¡æ£èã çåŸç©ã ã
ãšãããã éšåè³åããŸãã
ãšãããã éšåè³åããŸãã
æ¥æ¬ã¯WHOãšã¯å¥ã®èŠè§£ã§ã
äºäŸ¡ã¯ã¯ãã³ãæãŠãš
äºäŸ¡ã¯ã¯ãã³ãŠæ¥æ¬äººã人äœå®éšã«ãããŠããŸãããw
ãããæ¯ã®ïŒ€ïŒ®Aã人ã®ã²ãã ã«ã€ã³ã¹ããŒã«çæ
äºäŸ¡ã¯ã¯ãã³ãæãŠãš
äºäŸ¡ã¯ã¯ãã³ãŠæ¥æ¬äººã人äœå®éšã«ãããŠããŸãããw
ãããæ¯ã®ïŒ€ïŒ®Aã人ã®ã²ãã ã«ã€ã³ã¹ããŒã«çæ
æããã人ã¯äžå®ã«ãªããããã
ã§ãéã«ãããããããŸã§æ°ã«ããªãããæãããã®ãããã©ããªãã ãããªã»ã»ã»ã
ãŸãã©ãã§ããããã»ã»ã»ãç¬
ã§ãéã«ãããããããŸã§æ°ã«ããªãããæãããã®ãããã©ããªãã ãããªã»ã»ã»ã
ãŸãã©ãã§ããããã»ã»ã»ãç¬
ããããã
whoã®äžæãœãŒã¹èŠã€ããããŠãžããã©ãããã®èšäºã§ã¯ãæã£ãŠãªããã¢ããå ã«æãããªããããšãããšãã¿ããããã
åŸã¯éã®åé¡ã
whoã®äžæãœãŒã¹èŠã€ããããŠãžããã©ãããã®èšäºã§ã¯ãæã£ãŠãªããã¢ããå ã«æãããªããããšãããšãã¿ããããã
åŸã¯éã®åé¡ã
è¯ãã£ã(*'Ï'*)
家æãæã£ãŠãªãïŒïŒïŒïŒïŒ
家æãæã£ãŠãªãïŒïŒïŒïŒïŒ
å¿
èŠãªãïŒ
ã ã¶ãã ããã¡ããŒãèšããšããŸãã
ã ã¶ãã ããã¡ããŒãèšããšããŸãã
ãšããã³ã¹ãæé ããŠæšå¥šããŠãæ¢åŸæš©çã§ããã人ã®åœããªããšãæã£ãŠãªãããããããããšãã£ãŠãã§ãããæ€ããæãããã
ãããããããã
ãã®åŸãã¢ã³ãã³ã¡ã³ãã®åµã ãâŒïž
ã³ã€ããåçãã¹ãããªâŒïž
ã³ã€ããåçãã¹ãããªâŒïž
è
¹ç«ã€ïŒæããïŒãªãã§ãããªå¥Žãã®èšããªãã«ãªããªãããªããã®ïŒãã·ã«ã¯ãªããããããªããã©å¬ãããªããå
šãããŒãã
ããðãã¬ãã§å ±éãããŠãŸããïŒ
å¥åº·ãªåã©ããé幎ã¯ã¯ã¯ãã³æ¥çš®ã®åªå 床ãäœãã
ã³ããã¯ã¯ãã³ãïŒåæ¥çš®ããããšã«è¿œå æ¥çš®ãåãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã ã¯è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãã
å¥åº·ãªåã©ããé幎ã¯ã¯ã¯ãã³æ¥çš®ã®åªå 床ãäœãã
ã³ããã¯ã¯ãã³ãïŒåæ¥çš®ããããšã«è¿œå æ¥çš®ãåãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã ã¯è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãã
æ£ã
æã¡ãŸãã£ãŠãããŠäœãä¿®æ£ã
ãããïŒ
ïŒThe low priority group includes healthy children and adolescents aged 6 months to 17 years.
ãå¿ èŠãªããã§ã¯ãªããåªå 床ãäœããã§ã¯ïŒ
èŠåºãè©æ¬ºã§ããïŒ
ïŒThe low priority group includes healthy children and adolescents aged 6 months to 17 years.
ãå¿ èŠãªããã§ã¯ãªããåªå 床ãäœããã§ã¯ïŒ
èŠåºãè©æ¬ºã§ããïŒ
åçŽã«æžãã°
WHO åäŸãšè¥è ã«å®å šã§å¹æçãäœãçŸç ãªã¹ã¯ã¯äœãããè²»çšå¯Ÿå¹æãèããŠæ¥çš®ã決ããŠ
ãã€ã¿ãŒ åã©ããé幎ã¯å¿ ãããæ¥çš®ããå¿ èŠã¯ãªã
ãã¥ã¢ã³ã¹ãå転ããŠã
WHO åäŸãšè¥è ã«å®å šã§å¹æçãäœãçŸç ãªã¹ã¯ã¯äœãããè²»çšå¯Ÿå¹æãèããŠæ¥çš®ã決ããŠ
ãã€ã¿ãŒ åã©ããé幎ã¯å¿ ãããæ¥çš®ããå¿ èŠã¯ãªã
ãã¥ã¢ã³ã¹ãå転ããŠã
å¹æãªããããã被害ã ããå¢ããã ãã§ããããããããŠãã ããã
ä»æŽïŒ
æ¥æ¬æ¿åºã¯åœæ°ã«ã©ã説æããã®ã§ããããïŒ
ã©ã責任åã£ãŠãããã®ã§ããããïŒ
æ¥æ¬æ¿åºã¯åœæ°ã«ã©ã説æããã®ã§ããããïŒ
ã©ã責任åã£ãŠãããã®ã§ããããïŒ
ä»æŽä¿®æ£ã¯è
ïŒå¹Žçµã£ãŠãã£ãšãããŸã§æ¥ãããæ¥æ¬ããããããã£ãŠãã第ïŒæ³¢ã®åœ±é¿ãå°ãªãããšãç¥ãã°ããã
â·
â·
é«éœ¢è
ã»éã䜵åçŸæ£ãããæ人ã»å
ç«äžå
šã®äººã»åŠå©Šã»å»çåŸäºè
ãæããã6ãæãã12ãæããšã®å®ææ¥çš®ãæšå¥šãããð¢ð¢ð¢
ââã¿ããªèŠããªãïŒââ
ââæ¯ç©ãå§ãããªã£ââ
ââã¿ããªèŠããªãïŒââ
ââæ¯ç©ãå§ãããªã£ââ
ããã«å¯ŸããŠãã¯ã¯ãã³åŒ·å¶ãããããšãã人ãã¯ã©ã説æãããã ããã
ç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªã
ãïŒ
ãïŒ
æ¿æšãå»ã¯ã©ã誀蚳ã äœã ãšéšãã§ããããããããWHOèªäœã©ãã§ãããæ©é¢ã
ç¥ã£ãŠãïŒ
翻蚳ãã¹ãïŒWHOã®åæã¯ãããªããšæžããŠãªãã
> å¥åº·ãªåã©ããé幎ã¯å¿ ãããæ¥çš®ããå¿ èŠã¯ãªãã
> å¥åº·ãªåã©ããé幎ã¯å¿ ãããæ¥çš®ããå¿ èŠã¯ãªãã
æ¥æ¬ã¯æªã ã«åäŸã«ã¯ã¯æã£ãŠãŸããã
ãã£ãšæ©ãããèšãïŒ
ãšããšã倧ããªæ¯è»ãå€ãããŸããã
ã¿ã€ãã«ã®ãããªäºã¯æžããŠãªãããã
ãã¹ã³ãã¯ãŸãåãã€ã
ãã¹ã³ãã¯ãŸãåãã€ã
ä»æŽããððð
WHOã¯ãèšæ£ããã ããŸã ãã·ã
æ¿æ²»å®¶ã¯ããŸããŸãä¿¡é Œã倱ãã
1çªãã¡ãªã®ã¯ã³ãããç œãã ãç œã£ãŠ
èŠèŽçãšã¹ãã³ãµãŒåå ¥ã«éé²ãããã¹ãŽããã¯ã¯ãã³æšé²æŽŸã®ã³ã¡ã³ããŒã¿ãŒåãã ãã絶察責任åãããMCã®é¡ãèŠãã®ãå«ã
æ¿æ²»å®¶ã¯ããŸããŸãä¿¡é Œã倱ãã
1çªãã¡ãªã®ã¯ã³ãããç œãã ãç œã£ãŠ
èŠèŽçãšã¹ãã³ãµãŒåå ¥ã«éé²ãããã¹ãŽããã¯ã¯ãã³æšé²æŽŸã®ã³ã¡ã³ããŒã¿ãŒåãã ãã絶察責任åãããMCã®é¡ãèŠãã®ãå«ã
ãªã¹ã¯ç¡ã人ã¯æã€å¿
èŠç¡ãã
ãŠã±ã !
ããã¯ãã³ããã«ããææãã¯ã¯ãã³æ¥çš®ã®åºããã«äŒŽãäžççã«é«æ°Žæºã®éå£å
ç«ãååšããããšãèæ
®ããäžã§ãã®å§åãªã®ã§ãã¿ã€ãã«ã¯å£®å€§ãªé£ãéãªã®ã ããå¥ããããã®é£ãéã¯ãèªåã®é ã§äžæ¬¡æ
å ±ãåæã§ãããã©ãããã®ãªããã¹è©ŠéšçŽã«ãªã£ãŠããã®ãèå³æ·±ãð€
ãªãã»ã©
ããããä»æ¥ã¯1çªã³ã¬ãèšãããã£ããã§ãããã
ã¯ã¯ãã³æ¥çš®ïŒ
ãå¥åº·ãªåã©ãå¿ èŠãªãã
ã¯ã¯ãã³æ¥çš®ïŒ
ãå¥åº·ãªåã©ãå¿ èŠãªãã
ã¿ããªå¥åº·ãªã®ã«ãã倪éãã¡ãã£ã¢ ã¯ãœééã©ãã«éšãããŠæã¡ãŸããã
ãŸãããããã®ãå»è
ãããã¯ã¯ãã³ã¯å¿
èŠãªãå¿
èŠãªãã©ãããå±éºã ãšèšã£ãŠãããããã
ã©ã責任åãã€ããã§ããïŒ
ãã£
ç§ã¯æã£ãŠãªããã ãã©âŠãã®åœå€ã人5åæ¥çš®ããŠãªãã£ããïŒ
ç§ã¯æã£ãŠãªããã ãã©âŠãã®åœå€ã人5åæ¥çš®ããŠãªãã£ããïŒ
äœãä»ããâŠããŸããæãã³ããªãã
â
ïŒåæ¥çš®ããããšã«è¿œå æ¥çš®ãåãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã ã¯è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãâ
ïŒåæ¥çš®ããããšã«è¿œå æ¥çš®ãåãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã ã¯è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãâ
ã圹æã®å§å¥šã§5åæ¥çš®ãåããã®ã«ããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãããšã¯ã©ãããããšãããªã¬ãæèãèªã¿éããŠãã®ãïŒ
å¥åº·ãªåã©ããé幎ã¯ã¯ã¯ãã³æ¥çš®ã®ãåªå
床ãäœãã
ããã«æ¥ãŠWHOã,ãããªäºãèšãã ããŸããæ¥æ¬ã§ãã¯ã¯ãã³ã®ãã¬ãã£ããªæ å ±ãåºãŠããã®ãèŠèšãã£ãŠã,ããã§ã
ããã«æ¥ãŠWHOã,ãããªäºãèšãã ããŸããæ¥æ¬ã§ãã¯ã¯ãã³ã®ãã¬ãã£ããªæ å ±ãåºãŠããã®ãèŠèšãã£ãŠã,ããã§ã
é
ãã
äžæ¹ãå¥åº·ãªåã©ããé幎ã¯ã¯ã¯ãã³æ¥çš®ã®ãåªå
床ãäœãããšãããã®ãããªã°ã«ãŒããžã®æ¥çš®ãæšå¥šããåã«çŸç
è² æ
ãªã©ãèæ
®ããããååœã«èŠè«ã
ãŠæžããŠããã©ïŒïŒïŒ
ãŠæžããŠããã©ïŒïŒïŒ
ãã€ã¿ãŒã¯ãã£ãšã²ã©ãã®ãã
æ¥æ¬äººã®æ£è§£çã¯10%
äŒç€Ÿã®åŒ·å¶ããã£ããšã¯ãã
å€æãé£ããã£ãã
ç§ã¯éè¯ãæ¥çš®åã«è¬å®³ã ãšæ°ã¥ããã®ã§éãè¯ãã£ããšæã£ãŠãŸã
äŒç€Ÿã®åŒ·å¶ããã£ããšã¯ãã
å€æãé£ããã£ãã
ç§ã¯éè¯ãæ¥çš®åã«è¬å®³ã ãšæ°ã¥ããã®ã§éãè¯ãã£ããšæã£ãŠãŸã
梯åãå€ãããã³ããè³
å èŠã®æãªãããã
å èŠã®æãªãããã
極æªéé
ã¯ã¯ãã³æŽŸãæ¯ããŠãŸãã?
ç¹ã«ãåäŸã«å°ãŠããšãã£ãŠãã人éã
ä»ã©ããªæ°æã¡?
ããããããwww
ç¹ã«ãåäŸã«å°ãŠããšãã£ãŠãã人éã
ä»ã©ããªæ°æã¡?
ããããããwww
ãã³ãããã¯ã®æ°ããªæ®µéã«åãããæªçœ®ã§ãå¥åº·ãªåã©ããé幎ã¯å¿
ãããæ¥çš®ããå¿
èŠã¯ãªããããªã¹ã¯ã®é«ãã°ã«ãŒãã¯ååã®ã¯ã¯ãã³æ¥çš®ãã6-12ã«æåŸã«è¿œå æ¥çš®ïŒããŒã¹ã¿ãŒæ¥çš®ïŒãåããããææ¡âŠ
ãã£ãšããwww
"å¥åº·ãªåã©ããé幎ã¯ã¯ã¯ãã³æ¥çš®ã®ãåªå
床ãäœãã å¿
èŠãªã"ãšã¯ã©ãã«ãæžããŠãªãð¢
ãã®èšäºã貌ãã€ããŠãã€ãŒãããŠãã³ã¡ã³ãããã€ãèŠããšåéããå€ãã
è¿œå æ¥çš®=ããŒã¹ã¿ãŒæ¥çš®ã ããèŠã¯4åç®ä»¥éæšå¥šããªãã£ãŠããšãã®ã«ãæ è¡å²åŒã®çºã«3åç®å°ã£ãã®ã«ðãšãâŠ
è¿œå æ¥çš®=ããŒã¹ã¿ãŒæ¥çš®ã ããèŠã¯4åç®ä»¥éæšå¥šããªãã£ãŠããšãã®ã«ãæ è¡å²åŒã®çºã«3åç®å°ã£ãã®ã«ðãšãâŠ
ä»ããããªã«ãæåå§åãä¿®æ£ããâŒïž
ã©ãã ãã®äººéãèŠããã§ããšæã£ãŠãããâïžãã±ãŒãŒãŒã£ðð¡ð¢
ã©ãã ãã®äººéãèŠããã§ããšæã£ãŠãããâïžãã±ãŒãŒãŒã£ðð¡ð¢
ãããã²ã©ã誀蚳ã ãªã
åæã®"SAGE updates COVID-19 vaccination guidance
"ã«ã¯ãå¥åº·ãªåã©ããé幎ã¯ãåªå é äœã®äœãã°ã«ãŒãããšããã ãã§ãå¿ èŠãªãããšããèªã¯ãªãã£ãã
åæã®"SAGE updates COVID-19 vaccination guidance
"ã«ã¯ãå¥åº·ãªåã©ããé幎ã¯ãåªå é äœã®äœãã°ã«ãŒãããšããã ãã§ãå¿ èŠãªãããšããèªã¯ãªãã£ãã
å¥åº·ãªè¥ãäžä»£ãªãåããå¿
èŠããªããšä¿®æ£ããã¯ã¯ãã³æ¥çš®
ãšã¯ãã
ã¯ã¯ãã³ãå®å šâïžãšããŠããããWHOã¯âŠ
å±±äžç«¹æ¥ 暪æµåžé·ã¯æªã ã«
ã³ãã察çïŒã¯ã¯ãã³æ¥çš®
WHOã®ä¿®æ£ã¯ç¥ã£ãŠããã®ãïŒ
å±±äžæ°ã®ã¯ã¯ãã³äžæ¬ææ³
ä»åŸã©ãããã®ãïŒ
ãšã¯ãã
ã¯ã¯ãã³ãå®å šâïžãšããŠããããWHOã¯âŠ
å±±äžç«¹æ¥ 暪æµåžé·ã¯æªã ã«
ã³ãã察çïŒã¯ã¯ãã³æ¥çš®
WHOã®ä¿®æ£ã¯ç¥ã£ãŠããã®ãïŒ
å±±äžæ°ã®ã¯ã¯ãã³äžæ¬ææ³
ä»åŸã©ãããã®ãïŒ
ðŽä¿åçšðŽ
åã©ãã«ãŸã§æšå¥šããŠãã®æ¥æ¬ã ãã ã£ããã©ã
WHOãèšãåºãããã
å¹æããªããå¯äœçšã®ãªã¹ã¯ã ãããæ®ããªããªã
ãã¯ããšãããæ¬åœã«ãªã¹ã¯ãããªãã£ããšæãã
WHOãèšãåºãããã
å¹æããªããå¯äœçšã®ãªã¹ã¯ã ãããæ®ããªããªã
ãã¯ããšãããæ¬åœã«ãªã¹ã¯ãããªãã£ããšæãã
æ¥æ¬ã§ã¯ããŸã ã«æšå¥šããŠãŸãïŒ
⊠ã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£ å¥åº·ãªåã©ãå¿ èŠãªã
⊠ã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£ å¥åº·ãªåã©ãå¿ èŠãªã
ãªãããããªé²éªšã§æ°ã¥ããªã人ãããã£ãŠæããšæãã
WHOãã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£
ãå¥åº·ãªåã©ãã¯å¿ èŠãªãã
ããããŸãã¬ãã§èšããªã¢ã«ã³ãã€âŒïž
NHKã¯ãâŒïž
ãå¥åº·ãªåã©ãã¯å¿ èŠãªãã
ããããŸãã¬ãã§èšããªã¢ã«ã³ãã€âŒïž
NHKã¯ãâŒïž
å¥åº·ãªåäŸã«ãæã£ãŠæã£ãŠæã¡ãŸãã掟ã®äººéã©ããã£ãïŒð
ãã£ãšïŒä»æŽïŒ
è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªã
ã§ããããããã
è¿œå ã§ã¯ã¯ãã³ãæ¥çš®ããŠããã®ã¡ãªããã¯ãããã§ããããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªã
ã§ããããããã
ä»ãããå
容ãäžéå端ã§ããããŸãåºãð
æ¬åœã¯æ²»éšãšããåã®äººäœå®éšçµäº
ããååå²ãããããããäœã«ããšããããŒã£ãŠäºã§ãããã
ã©ãããã®ã³ã¬ïŒãŸãå
ã
åäŸã«ã¯ã¯ãã³ã¯å¿
èŠãªãããšã¯çµ±èšããŒã¿ã§æããã ã£ããã©ãæšå¹Žã¯ã¯ãã³ãæã£ãŠé¢šåå Žã§äº¡ããªã£ãéçå°å¹Žãäžæ«ã§ãªããªãã
æ¥çš®ããŠäº¡ããªã£ãå¥åº·ãªåã©ãã¯ãéãæªãã£ã(å æé¢ä¿äžæ)ãšã§ãããã®ãïŒ
æããªããä»ã®æªæ¥ããã£ãããã®äººçã朰ããã®ã ã
æããªããä»ã®æªæ¥ããã£ãããã®äººçã朰ããã®ã ã
WHOã®æ¥çš®ãããä¿¡çšããªãã£ãã®ã§ãæ¥çš®ããããä¿¡çšããªããèªåã®èãã«ãªã£ããããã»ãããã¯éããšæãã
WHOã®ã¬ã€ãã³ã¹æ¹å®ãªã®ã ããå¥åº·ãªåäŸã®æ¥çš®åªå
床ãäœããªã£ãã ãã§ãäžèŠãšã¯çšé ãå
容ã
æ¿æ²»å®¶ãå«ãåã¯ã¯æŽ»å家ãå°èºãããŠçºä¿¡ããŠããããåæãèªãŸãªãã§ãã¥ãŒã¹ãä¿¡ããã®ã¯æããã®ã ã
æ¿æ²»å®¶ãå«ãåã¯ã¯æŽ»å家ãå°èºãããŠçºä¿¡ããŠããããåæãèªãŸãªãã§ãã¥ãŒã¹ãä¿¡ããã®ã¯æããã®ã ã
ããã®èŠåºãããã¹ãªãŒãã ãšããããªããšæžããŠãªãã£ãŠè©±ããã£ãšè©±ãã¯ã¯ãã³é¢ä¿ãªãæ¥æ¬ã®ããããã¥ãŒã¹éçšã«ãããæ ¹æ·±ããšããã«ãã£ãŠãå€åæ
åœãäœãèããã«æ¥æ¬æ³äººã®éåžžãªãã¬ãŒã·ã§ã³ã§åºããŠããã ãšæãã
ãããããåŸåãããã©ãããååŽçã芪ã®æšã¿ã¯å¿åºæããããã
ããããã°ãæ¥æ¬ã®ã¯ã¯ãã³æ¥çš®ã¯ã©ããªã£ããã ïŒ
ïŒåæ¥çš®ããåŸã«è¿œå æ¥çš®ãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã¯ãè¿œå ã§ã¯ã¯ãã³æ¥çš®ããŠãã¡ãªããå ãã®ãããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãâŠ
ã£ãŠæžããŠãããã©
ããã£ãŠã©ãããæå³ããªïŒð
ïŒåæ¥çš®ããåŸã«è¿œå æ¥çš®ãããäžçšåºŠã®ãªã¹ã¯ããæ±ãã人ã¯ãè¿œå ã§ã¯ã¯ãã³æ¥çš®ããŠãã¡ãªããå ãã®ãããç¹°ãè¿ãã®æ¥çš®ã¯æšå¥šãããªãâŠ
ã£ãŠæžããŠãããã©
ããã£ãŠã©ãããæå³ããªïŒð
å¿
èŠãªããšã¯ãã£ãŠãªããçŸç
è² æ
ãè²»çšå¯Ÿå¹æãèæ
®ãããšãã£ãŠããããããã誀解ãæãèªå°çãªèŠåºããããããåã³ããã¹ã³ããïŒ
ãŸã æ¥æ¬ã§ãæ²»éšããã£ãŠãããã©w
é
ããª
ãã®ããã
ãå»çåŸäºè ã®ã»ããé«éœ¢è ãç³å°¿ç ãå¿çŸæ£ãªã©ã®åºç€çŸæ£ããã人ãå ç«äžå šã®äººãããã«åŠå©Šã«ã€ããŠã¯ãæãåªå 床ãé«ããšããŠãå幎ãŸãã¯1幎ããšã®å®æçãªæ¥çš®ãæšå¥šã
ããããæã£ãããã¡ãããïŒ
ãå»çåŸäºè ã®ã»ããé«éœ¢è ãç³å°¿ç ãå¿çŸæ£ãªã©ã®åºç€çŸæ£ããã人ãå ç«äžå šã®äººãããã«åŠå©Šã«ã€ããŠã¯ãæãåªå 床ãé«ããšããŠãå幎ãŸãã¯1幎ããšã®å®æçãªæ¥çš®ãæšå¥šã
ããããæã£ãããã¡ãããïŒ
WHOãå
šå¹Žä»£ã§ã³ããã¯ã¯ãã³ã¯å®å
šã§å¹æçã§ããã
ïŒãã ã¯ã¯ãã³ãéãããŠããããç¹ã«è¿œå æ¥çš®ã¯åªå é äœãã€ããŸããããïŒã
â
ãã€ã¿ãŒãWHOãå¥åº·ãªåäŸã«ã¯ã¯ã¯ãã³ãå¿ èŠãªãã£ãŠèšã£ãïŒïŒã
å®å šãªæé ã¬ãã«ã®é ·ãèŠåºãã§ããã
ïŒãã ã¯ã¯ãã³ãéãããŠããããç¹ã«è¿œå æ¥çš®ã¯åªå é äœãã€ããŸããããïŒã
â
ãã€ã¿ãŒãWHOãå¥åº·ãªåäŸã«ã¯ã¯ã¯ãã³ãå¿ èŠãªãã£ãŠèšã£ãïŒïŒã
å®å šãªæé ã¬ãã«ã®é ·ãèŠåºãã§ããã
ãã£ãšã³ããã¯ã¯ãã³ããŒã çµãã£ã
ããã«ããŠãã€ã³ãã«ãšã³ãµãŒã®ç œããããã£ããª
ããªãšã¢ã³ãæããªããã€ãã«ã
ã²ããããæããªã人ã¯é æªãé°è¬è«è ãåŠå©Šãæã£ãæ¹ãããã
ãã¹ã¿ãåã£ãŠãæè³å®¶ã»ã©æã£ãŠãã
æç°æ èŒãæããªããšæ¥æ¬ã®GDPäžããã
ããã«ããŠãã€ã³ãã«ãšã³ãµãŒã®ç œããããã£ããª
ããªãšã¢ã³ãæããªããã€ãã«ã
ã²ããããæããªã人ã¯é æªãé°è¬è«è ãåŠå©Šãæã£ãæ¹ãããã
ãã¹ã¿ãåã£ãŠãæè³å®¶ã»ã©æã£ãŠãã
æç°æ èŒãæããªããšæ¥æ¬ã®GDPäžããã
ããŠãåäŸãæãŠæãŠãšåãç«ãŠãŠããå»è
æ§æ¹ã¯ãã©ãåãã€ããããªïŒ
å¥åº·ãªåäŸã«ã¯ã¯ãã³æ¥çš®ã¯å¿
ãããå¿
èŠã§ã¯ãªãããšä¿®æ£ãå
¥ããŸãã
ã§ããŒåŸåºãw
ãŸãæã£ã人ã¯ãªãã®ããŒã¿ããªãã®ã«èªãå®éšå°ã«ãªã£ãããã ãããä»åŸãªã«ãèµ·ãã£ãŠãæå¥ã¯èšããªãããã
åœãïŸïœŒïŸïŸïŸïŸïŸïœ°ãšããã¢ãããã§ããã
ãŸãæã£ã人ã¯ãªãã®ããŒã¿ããªãã®ã«èªãå®éšå°ã«ãªã£ãããã ãããä»åŸãªã«ãèµ·ãã£ãŠãæå¥ã¯èšããªãããã
åœãïŸïœŒïŸïŸïŸïŸïŸïœ°ãšããã¢ãããã§ããã
WHOã¯æ¥çš®æéãå¥åº·ãªæ人ãåã©ãã«ã¯å®æçãªè¿œå æ¥çš®ããæšå¥šããªããã«æ¹å®ããããã§ãã
ãã以äžåäŸéã«å¥åº·è¢«å®³ãåºãããªãäºãç¥ããŸãã
ãã以äžåäŸéã«å¥åº·è¢«å®³ãåºãããªãäºãç¥ããŸãã
WHOã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£
NHKãã¥ãŒã¹ã§ã¯å ±éããã
ä»æ¥ã®ã¯ã¯ãã³æ¥çš®äººæ°ã®ã«ãŠã³ãã¯æŸé
NHKãã¥ãŒã¹ã§ã¯å ±éããã
ä»æ¥ã®ã¯ã¯ãã³æ¥çš®äººæ°ã®ã«ãŠã³ãã¯æŸé
ã»å¥åº·ãªåäŸãé幎ã¯å¿
ãããæ¥çš®ããå¿
èŠã¯ãªã
ã»é«ãªã¹ã¯è ã¯ååæ¥çš®ãã6ïœ12ã«æåŸã®è¿œå æ¥çš®ã
ã»3åæ¥çš®æžã®äžçšåºŠã®ãªã¹ã¯è ã«ã¯è¿œå æ¥çš®ã®ã¡ãªããã¯å ã
ãWHOãã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£ã
ã»é«ãªã¹ã¯è ã¯ååæ¥çš®ãã6ïœ12ã«æåŸã®è¿œå æ¥çš®ã
ã»3åæ¥çš®æžã®äžçšåºŠã®ãªã¹ã¯è ã«ã¯è¿œå æ¥çš®ã®ã¡ãªããã¯å ã
ãWHOãã³ããã¯ã¯ãã³æ¥çš®å§åãä¿®æ£ã
é¡åãð
ââïžãã§ãããªäºèšã£ãŠãªããã¿ã€ãã«èšæ£ããã»ããããããããããã€ã¿ãŒããŽããªãããªã
ãŸã é 匵ããšããã
ãCOVIDã¯äººã«ããå±éºãªçç¶ãèµ·ããäžæ¹ãã¯ã¯ãã³ã«ã¯æ¥µããŠé«ãå®å šæ§ãšéçäºé²å¹æãããããšã«å€ããã¯ãããŸãã
ãæ¿åºã®æçã«ããå床ã®æ³¢ã®äºå ããããŸã
ãé«ãæ¥çš®çã®æ¬§ç±³ãšæ¥æ¬ã¯åãããã«ã¯ã§ããŸãã
ãããã§ãããã
ãCOVIDã¯äººã«ããå±éºãªçç¶ãèµ·ããäžæ¹ãã¯ã¯ãã³ã«ã¯æ¥µããŠé«ãå®å šæ§ãšéçäºé²å¹æãããããšã«å€ããã¯ãããŸãã
ãæ¿åºã®æçã«ããå床ã®æ³¢ã®äºå ããããŸã
ãé«ãæ¥çš®çã®æ¬§ç±³ãšæ¥æ¬ã¯åãããã«ã¯ã§ããŸãã
ãããã§ãããã
å°ãªããšããã£ãŸãç§ã®åšãã§æã£ã人ãã¡
åºç€çŸæ£ããã£ã人ãã¡ã¯ãã®äžããããªããªããæ¥åžžç掻ãéããŠããªã
ãããŠåŠå©Šããã¯ããšããšãæµç£ãåŠåš äžã«åå®®ãããèŠã€ãã£ããããŠãããð¢
åºç€çŸæ£ããã£ã人ãã¡ã¯ãã®äžããããªããªããæ¥åžžç掻ãéããŠããªã
ãããŠåŠå©Šããã¯ããšããšãæµç£ãåŠåš äžã«åå®®ãããèŠã€ãã£ããããŠãããð¢
åäŸãè¥ã人ã¯æ¥çš®ããå¿ èŠã¯ãªã
ç¹°ãè¿ãæ¥çš®ããããšã¯æšå¥šããªã
ãªã©ãšã®ããŸã£ãŠããããã